On 22 June 2012, a case of locally acquired malaria infection was reported in Greece. The case is a 78 year old Greek citizen who presumably acquired the infection close to Marathon, Attica region.
4CMenB has the potential to reduce serogroup B meningococcal disease substantially. Despite its potential, the vaccine may have some limitations, and it remains to be seen if booster doses will be required to sustain protection.
Between 21 May and 5 December, 2011, 63 cases of Plasmodium vivax infection have been reported in Greece. The majority of cases (n=57) are reported from the area of Evrotas in Lakonia district, Peloponnese in southern Greece.
Universal screening of pregnant women is feasible and has led to immunisation in nearly all identified cases in Denmark. As a consequence of the study the National Board of Health has made universal HBsAg screening of pregnant women permanent in the country.
According to the available epidemiological and entomological information, and the arriving winter season, the intensity of malaria transmission in Evrotas, Lakonia in Greece is very low.
According to the available epidemiological and entomological information, and the arriving winter season, the intensity of malaria transmission in Evrotas, Lakonia in Greece is believed to be very low and is expected to cease shortly.
56 adult patients with PCR confirmed P. knowlesi malaria from Sabah are described. 22 (39%) of these had strictly defined severe malaria including respiratory distress, acute renal failure and shock.